Mustang Bio, Inc. (MBIO) Financials

MBIO Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 17.7 million 17.6 million
2023-09-30 20.6 million 16.6 million
2023-06-30 29.1 million 15.4 million
2023-03-31 73.6 million 43.8 million

MBIO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -7.3 million 188000
2023-09-30 -12.1 million 100000
2023-06-30 -12.4 million 45000
2023-03-31 -17.8 million 235000

MBIO Net Income

No data available :(

MBIO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 6.2 million - 2.5 million
2023-09-30 9.6 million - 2.6 million
2023-06-30 15.4 million - 2.6 million
2023-03-31 58.1 million 27.6 million 3.9 million

MBIO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 9.2 million
2023-09-30 8.2 million
2023-06-30 8.1 million
2023-03-31 8.1 million

MBIO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 30000 6.4 million 2.2 million 79000
2023-09-30 50000 9.5 million 2.1 million -
2023-06-30 34000 10.8 million 3.1 million -
2023-03-31 18000 14.0 million 2.3 million -

MBIO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 363000
2023-09-30 - 1.4 million
2023-06-30 - 698000
2023-03-31 - 858000

MBIO

Price: $0.32

52 week price:
0.32
8.17

Earnings Per Share: -6.00 USD

P/E Ratio: -0.15

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 169948

Ebitda: -6.9 million

Market Capitalization: 5.3 million

Links: